PECAM Identified as Gatekeeper in Eye Inflammation

A recent study published in *The American Journal of Pathology* demonstrates that immune cells access the retina through the body’s conventional vascular route, with platelet endothelial cell adhesion molecule‑1 (PECAM‑1) acting as the primary gatekeeper. The researchers identified neutrophils as key pro‑resolving mediators that enter the retinal tissue via this pathway, suggesting a more nuanced role for these cells in ocular inflammation than previously understood.

The investigators used advanced imaging and molecular techniques to trace the migration of neutrophils from the bloodstream into the retinal layers, revealing that PECAM‑1 facilitates their passage across the retinal vasculature. This finding clarifies the cellular dynamics underlying retinal inflammatory responses and highlights potential targets for therapeutic intervention, particularly in diseases where dysregulated inflammation contributes to vision loss.

By elucidating the mechanism of immune cell entry into the retina, the study provides a foundation for developing more precise anti‑inflammatory treatments. Future research may explore how modulating PECAM‑1 activity or neutrophil function could mitigate retinal damage in conditions such as diabetic retinopathy and age‑related macular degeneration.